Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.106NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.11NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
XBB.1.5.11NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XBB.1.5.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-552.006Thailand
XBB.1.5.11NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4848.65Thailand
XBB.1.5.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
XBB.1.5.11NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
XBB.1.5.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
XBB.1.5.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.11NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.1.5.11NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.11NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.1.5.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.5.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-19891.3Japan
XBB.1.5.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.5.11NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
XBB.1.5.11NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.1.5.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FE.1.1.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
FE.1.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FE.1.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FE.1.1.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
FE.1.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FE.1.1.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
FE.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FE.1.1.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FE.1.1.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
FE.1.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FE.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FE.1.1.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FE.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FE.1.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FE.1.1.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FE.1.1.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FE.1.1.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
FE.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FE.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FE.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.4.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used